Effect of cytogenin, a novel immunomodulator, on streptozotocin-induced diabetes in mice

J Antibiot (Tokyo). 2005 Mar;58(3):202-5. doi: 10.1038/ja.2005.24.

Abstract

The anti-diabetic effect of cytogenin was examined using streptozotocin-induced diabetes in mice. Cytogenin suppressed not only the increase of plasma glucose level but also the body weight reduction in diabetic mice. Histological examination of the pancreas taken from diabetic mice given cytogenin showed that cytogenin decreased the number of macrophages infiltrated into islet of pancreas. Further, cytogenin suppressed the nitric oxide generation by macrophages treated with lipopolysaccharide through decreasing of inducible nitric oxide synthase expression. Cytogenin suppressed interleukin-6 expression by macrophage treated with LPS, suggesting that the anti-diabetic activity of cytogenin might be partly attributed to the suppressive activity against nitric oxide generation.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Body Weight / drug effects
  • Coumarins / therapeutic use*
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / pathology
  • Diabetes Mellitus, Experimental / physiopathology
  • Female
  • Hypoglycemic Agents / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • In Vitro Techniques
  • Interleukin-6 / biosynthesis
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / pathology
  • Isocoumarins
  • Macrophages / drug effects
  • Macrophages / pathology
  • Macrophages / physiology
  • Mice
  • Nitric Oxide / biosynthesis

Substances

  • Blood Glucose
  • Coumarins
  • Hypoglycemic Agents
  • Immunologic Factors
  • Interleukin-6
  • Isocoumarins
  • cytogenin
  • Nitric Oxide